← Back to Analyst Consensus 
OBIO Buy
Orchestra BioMed Holdings, Inc.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 16, 2026 (21 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 23, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Sep 15, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| Sep 10, 2026 | BTIG | upgrade | Neutral → Buy | — | 52% |
| Aug 11, 2026 | Piper Sandler | reiterate | Overweight → Overweight | — | 54% |
| May 19, 2026 | B. Riley Securities | maintain | Buy → Buy | — | 55% |
| May 14, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 13, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Mar 12, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Jan 9, 2026 | Barclays | maintain | Overweight → Overweight | $12 | 53% |
| Dec 10, 2025 | TD Cowen | initiate | — → Buy | $15 | 54% |
| Nov 13, 2025 | Chardan Capital | maintain | Buy → Buy | $20 | 47% |
| Nov 12, 2025 | Barclays | maintain | Overweight → Overweight | $11 | 53% |
| Sep 4, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $10 | 44% |
| Aug 20, 2025 | BTIG | downgrade | Buy → Neutral | $0 | 52% |
| Aug 13, 2025 | Chardan Capital | maintain | Buy → Buy | $20 | 47% |
| Aug 7, 2025 | Chardan Capital | maintain | Buy → Buy | $20 | 47% |
| May 13, 2025 | Chardan Capital | maintain | Buy → Buy | $20 | 47% |
| May 5, 2025 | Barclays | maintain | Overweight → Overweight | $12 | 53% |
| Apr 22, 2025 | Chardan Capital | maintain | Buy → Buy | $20 | 47% |
| Apr 4, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $12 | 44% |
| Apr 1, 2025 | Chardan Capital | maintain | Buy → Buy | $20 | 47% |
| Mar 20, 2025 | BTIG | initiate | — → Buy | $12 | 52% |
| Mar 10, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| Jan 2, 2025 | Barclays | initiate | — → Overweight | $16 | 53% |
| Nov 15, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $14 | 44% |
| Nov 13, 2024 | Chardan Capital | maintain | Buy → Buy | $20 | 47% |
| Aug 22, 2024 | HC Wainwright & Co. | initiate | — → Buy | $14 | 44% |
| Jul 25, 2024 | B. Riley Securities | initiate | — → Buy | $15 | 55% |
| Jun 12, 2024 | Chardan Capital | reiterate | Buy → Buy | $20 | 47% |
| Mar 28, 2024 | Chardan Capital | maintain | Buy → Buy | $20 | 47% |
| Jan 19, 2024 | Jefferies | initiate | — → Buy | $14 | 52% |
| Aug 11, 2023 | Chardan Capital | reiterate | Buy → Buy | $20 | 47% |
| Aug 9, 2023 | Chardan Capital | reiterate | Buy → Buy | $20 | 47% |
| May 15, 2023 | Chardan Capital | reiterate | Buy → Buy | $20 | 47% |
| Feb 24, 2023 | Piper Sandler | initiate | — → Overweight | $15 | 54% |
| Feb 7, 2023 | Chardan Capital | initiate | — → Buy | $20 | 47% |
Price Target Trend
Apr 29, 2026 Oct 26, 2026
EPS Estimates
0y —
+1y —
0q —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days